TFSA Investors: Where to Invest $7,000 in 2024

Canadian investors can consider holding undervalued mid-cap growth stocks in their Tax-Free Savings Account, or TFSA.

| More on:

Canadian investors can consider holding a wide range of asset classes in a TFSA, or Tax-Free Savings Account, including stocks, bonds, mutual funds, Guaranteed Investment Certificates, and exchange-traded funds. Even in stocks, you can hold growth stocks, dividend stocks, or blue-chip stocks depending on factors such as your age, risk appetite, and investment horizon.

The TFSA contribution limit for 2024 has increased to $7,000 from $6,500 in 2023 and $6,000 in 2022. Here, I have identified two quality TSX stocks you can buy and hold in a TFSA right now.

Andlauer Healthcare Group stock

Valued at $1.6 billion by market cap, Andlauer Healthcare (TSX:AND) is a supply chain management company that offers an enterprise-facing platform of customized third-party logistics and specialized transportation solutions for the healthcare sector in Canada and the U.S.

It provides logistics and distribution services such as client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions, among others.

In the fourth quarter (Q4) of 2023, Andlauer Healthcare reported revenue of $169 million, an increase of 2% year over year. Its operating income stood at $28 million, while adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) totalled $44.8 million, indicating a margin of 26.5%.

Andlauer emphasized each of its product lines, with the exception of the packaging solutions segment, which returned to revenue growth in Q4. It experienced a decline in the truckload business in the U.S., a market that is now showing signs of stabilizing, while its Canadian transportation network remains robust.

Analysts tracking Andlauer Healthcare expect top-line growth to accelerate to 4.9% year over year to $676 million in 2024. The company’s adjusted earnings are also forecast to expand to $1.78 per share, indicating a reasonable forward earnings multiple of 21.9 times.

The company also pays shareholders a quarterly dividend of $0.09 per share, and the payouts have almost doubled in the last four years.

Evertz Technologies stock

Valued at $1.13 billion by market cap, Evertz Technologies (TSX:ET) designs, manufactures, and distributes video and audio infrastructure solutions for the production, broadcast, and telecom markets. It is among the leading players in the Software-Defined Video Network technology segment.

In fiscal Q2 of 2024 (which ended in October), Evertz reported revenue of $130.7 million, an increase of 15% year over year. International sales were a key driver of top-line growth, more than doubling to $56.7 million in Q2.

Moreover, operating income rose 13% to $32.3 million, while net income grew 11% to $22.3 million in the quarter.

The company pays investors an annual dividend of $0.78 per share, translating to a tasty yield of 5.22%. These payouts have risen from $0.08 per share in 2009 to $0.195 per share in 2024.

In the last 10 years, after adjusting for dividends, the TSX stock has returned just 61% to shareholders, trailing the broader markets by a wide margin.

Currently, Evertz stock trades at 15.9 times forward earnings, which is quite cheap, given adjusted earnings are forecast to expand by 18.8% annually in the next five years. Analysts remain bullish and expect shares to surge roughly 14% in the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Andlauer Healthcare Group. The Motley Fool has a disclosure policy.

More on Tech Stocks

chart reflected in eyeglass lenses
Tech Stocks

Top Canadian AI Stocks to Watch in 2025

Celestica (TSX:CLS) stock and another Canadian AI stock are worth watching closely this holiday season.

Read more »

Nvidia Voyager Headquarters
Tech Stocks

Why Nvidia Stock Rallied (Again) on Tuesday

The chipmaker is expected to report earnings this evening.

Read more »

hand stacking money coins
Tech Stocks

3 Growth Stocks That Are Screaming Buys in November

The market might be soaring, but there are still lots of deals to be had. Here are three discounted stocks…

Read more »

Rocket lift off through the clouds
Tech Stocks

Why I’d Buy Constellation Software Stock, Even at Today’s Prices

Despite trading at a relatively frothy multiple, Constellation Software (TSX:CSU) stock still looks like a buy right now.

Read more »

profit rises over time
Tech Stocks

2 Reasons to Buy Kinaxis Stock Like There’s No Tomorrow

Solid revenue growth, improving profitability, and its focus on AI-powered supply chain solutions make Kinaxis stock really attractive to buy…

Read more »

Muscles Drawn On Black board
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $500

If you have a bit of cash you're looking to set aside, these are the easiest tech stocks for some…

Read more »

how to save money
Tech Stocks

3 Reasons to Buy Shopify Stock Like There’s No Tomorrow

Here's why Shopify (TSX:SHOP) stock certainly looks like a buy for long-term growth investors looking for a top TSX stock.

Read more »

A child pretends to blast off into space.
Tech Stocks

2 Compelling Reasons to Snap Up Constellation Software Stock Now

Here's why I think Constellation Software (TSX:CSU) is a top-tier growth stock to own for the long-term right now.

Read more »